Pidotimod may prevent recurrent respiratory infections in children. 2014

A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
Immuno‑Pneumo‑Allergy Unit Department of Pediatrics, University of Pavia, Fondazione IRCCS San Matteo, Pavia, Italy - gl.marseglia@smatteo.pv.it.

OBJECTIVE Recurrent respiratory infections (RRI) constitute a social problem for both the pharmaco-economic impact and the burden for the family. Pidotimod is a synthetic immunostimulant. The aim of this study was to evaluate the effects of pidotimod on RRI prevention in children. METHODS Globally, 100 children (49 males, mean age 4.7 ± 1.2 years) with RRI were enrolled in the study. At baseline, children were randomly assigned to the treatment with pidotimod 400 mg/die or not for two months. Children were visited at baseline, after 30 (T1) and 60 (T2) days, and at follow-up (120 days; T3). Number of children with upper and lower airways symptoms, medications use, school attendance, and paediatric visits for RRI were evaluated. RESULTS Pidotimod treatment was able of significantly reducing the number of children with upper and lower airways symptoms, and medications use, increasing school attendance, and reducing pediatric visits for RRI. CONCLUSIONS This study provided the evidence that pidotimod may be able of preventing RRI in children.

UI MeSH Term Description Entries
D008297 Male Males
D011761 Pyrrolidonecarboxylic Acid A cyclized derivative of L-GLUTAMIC ACID. Elevated blood levels may be associated with problems of GLUTAMINE or GLUTATHIONE metabolism. 5-Oxoproline,Pidolic Acid,Pyroglutamic Acid,5-Ketoproline,5-Oxopyrrolidine-2-Carboxylic Acid,Magnesium Pidolate,Pyroglutamate,Pidolate, Magnesium
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
January 2019, Journal of biological regulators and homeostatic agents,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
December 1994, Arzneimittel-Forschung,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
December 1994, Arzneimittel-Forschung,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
December 1994, Arzneimittel-Forschung,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
December 1994, Arzneimittel-Forschung,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
March 2020, Italian journal of pediatrics,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
January 2014, International journal of immunopathology and pharmacology,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
August 2002, Minerva pediatrica,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
January 1975, La Revue du praticien,
A Licari, and M De Amici, and S Nigrisoli, and A Marseglia, and S Caimmi, and L Artusio, and G L Marseglia
August 2020, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
Copied contents to your clipboard!